🟢 Tenax Therapeutics is trading 17.57% up today after Adar1 Capital disclosed a $1.8 million share purchase

Tenax Therapeutics is trading 17.57% up at $2.17 after Adar1 Capital Management disclosed approximately $1.8 million in share purchases.

• The investment firm acquired more than 1 million shares at an average price of $1.77, increasing its holdings above 4.7 million shares.
• The buying disclosure was the clear company-specific catalyst behind the August 25, 2026 premarket and early-session rally, with broader biotech strength providing additional support.